Arrowhead Pharmaceuticals Inc (NAS:ARWR)
$ 25.5 1.71 (7.19%) Market Cap: 3.17 Bil Enterprise Value: 2.76 Bil PE Ratio: 0 PB Ratio: 6.54 GF Score: 54/100

Arrowhead Pharmaceuticals Inc Annual Shareholders Meeting Transcript

Mar 14, 2019 / 05:00PM GMT
Release Date Price: $18.55 (-3.89%)
Operator

The line is now open for the 2019 Annual Meeting of Stockholders of Arrowhead Pharmaceuticals.

Christopher R. Anzalone
Arrowhead Pharmaceuticals, Inc. - CEO, President & Director

Good morning, and thank you for joining our Virtual Meeting of Stockholders. I'm Christopher Anzalone, the President and CEO and Director of Arrowhead and will be serving as Chairman for today's meeting. The polls are open for voting. With us today are Doug Given, Chairman of the Board; Mike Perry, Lead Director and Chair of the Compensation and Nominating Committees; Mauro Ferrari, Director; Will Waddill, Director and Chair of the Audit Committee.

Also present are the following members of management: Jane Davidson, Corporate Secretary; Patrick O'Brien, General Counsel; Vince Anzalone, Vice President of Investor Relations; Damien Pineda of Rose, Snyder & Jacobs, our independent registered public accounting firm.

I hereby call this meeting to order. It has been duly called and a quorum is present in person or by proxy. Four proposals to be voted on were set

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot